References
- Green JL , AndersonV , DartRC , HeardK. Medication history assessment in research: a randomized controlled trial comparing tablet-based (eMedHAT) versus structured interview (MedHAT). Pharmacoepidemiol. Drug Saf.27(12), 1356–1360 (2018).
- Orive G , HernandezRM , GasconARet al. Cell encapsulation: promise and progress. Nat. Med.9(1), 104–107 (2003).
- Orive G , HernandezRM , RodriguezGascon Aet al. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol.22(2), 87–92 (2004).
- Abdelallah NH , AbdeltawabNF , BoseilaAA , AminMA. Chitosan and sodium alginate combinations are alternative, efficient and safe natural adjuvant systems for Hepatitis B vaccine in mouse model. Evid. Based Complement. Alternat. Med.2016, 7659684 (2016).
- Mooranian A , NegruljR , JamiesonE , MorahanG , Al-SalamiH. Biological assessments of encapsulated pancreatic β-cells: their potential transplantation in diabetes. Cell. Mol. Bioeng.9(4), 530–537 (2017).
- Mooranian A , ZamaniN , TakechiRet al. Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of Type 1 diabetes. Artif. Cells Nanomed. Biotechnol.46, 748–754 (2018).
- Mooranian A , ZamaniN , MikovMet al. Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatment. Ther. Deliv.10(2), 99–106 (2019).
- Whelehan M , MarisonIW. Microencapsulation using vibrating technology. J. Microencapsul.28(8), 669–688 (2011).
- Wang L , LiuY , PuF , ZhangW , ZhouZ. Effect of rotary evaporator water bath temperature on recovery rate of phthalate esters. Bull. Environ. Contam. Toxicol.101(6), 810–813 (2018).
- Sapra M , MayyaYS , VenkataramanC. Engineering of layered, lipid-encapsulated drug nanoparticles through spray-drying. Colloids Surf. B. Biointerfaces154, 178–185 (2017).
- Houten SM , WatanabeM , AuwerxJ. Endocrine functions of bile acids. EMBO J.25(7), 1419–1425 (2006).
- Lalic-Popovic M , VasovicV , MilijasevicB , Golocorbin-KonS , Al-SalamiH , MikovM. Deoxycholic acid as a modifier of the permeation of gliclazide through the blood brain barrier of a rat. J. Diabetes Res.2013, 598603 (2013). doi:10.1155/2013/598603
- Mathavan S , Chen-TanN , ArfusoF , Al-SalamiH. A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes. Drug Deliv.23(8), 2869–2880 (2016).
- Mathavan S , Chen-TanN , ArfusoF , Al-SalamiH. The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in Type 1 diabetes. Artif. Cells Nanomed. Biotechnol.44(6), 1508–1519 (2016).
- Mooranian A , NegruljR , MathavanSet al. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J. Pharm. Innov.9(2), 150–157 (2014).
- Mooranian A , NegruljR , TakechiR , JamiesonE , MorahanG , Al-SalamiH. New biotechnological microencapsulating methodology utilizing individualized gradient-screened jet laminar flow techniques for pancreatic beta-cell delivery: bile acids support cell energy-generating mechanisms. Mol. Pharm.14(8), 2711–2718 (2017).
- Sánchez L , SánchezP , DeLucas A , CarmonaM , RodríguezJF. Microencapsulation of PCMs with a polystyrene shell. Colloid Polym. Sci.285(12), 1377–1385 (2007).
- Al-Salami H , ButtG , TuckerI , MikovM. Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats. Pharmacol. Rep.60(4), 532–541 (2008).
- Al-Salami H , ButtG , TuckerI , SkrbicR , Golocorbin-KonS , MikovM. Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats. Arch. Drug Inf.1(1), 35–41 (2008).
- Al-Salami H , ButtG , TuckerI , Golocorbin-KonS , MikovM. Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats. Eur. J. Drug Metab. Pharmacokinet.37(2), 99–108 (2012).
- Mooranian A , TakechiR , JamiesonE , MorahanG , Al-SalamiH. The effect of molecular weights of microencapsulating polymers on viability of mouse-cloned pancreatic beta-cells: biomaterials, osmotic forces and potential applications in diabetes treatment. Pharm. Dev. Technol.23(2), 145–150 (2018).
- Mooranian A , NegruljR , Chen-TanNet al. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study. Drug Des. Devel. Ther.8, 1003–1012 (2014).
- Mooranian A , NegruljR , Chen-TanN , WattsGF , ArfusoF , Al-SalamiH. An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer. Drug Des. Devel. Ther.8, 1673–1683 (2014).
- Almutairy BK , AlshetailiAS , AshourEAet al. Development of a floating drug delivery system with superior buoyancy in gastric fluid using hot-melt extrusion coupled with pressurized CO2. Pharmazie71(3), 128–133 (2016).
- Yom-Tov O , SeliktarD , Bianco-PeledH. A modified emulsion gelation technique to improve buoyancy of hydrogel tablets for floating drug delivery systems. Mater. Sci. Eng. C Mater. Biol. Appl.55, 335–342 (2015).
- Hong SS , LeeSH , LeeYJ , ChungSJ , LeeMH , ShimCK. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide. J. Control. Rel.51(2-3), 185–192 (1998).
- Pal D , NayakAK. Development, optimization, and anti-diabetic activity of gliclazide-loaded alginate-methyl cellulose mucoadhesive microcapsules. AAPS PharmSciTech.12(4), 1431–1441 (2011).
- Prajapati SK , TripathiP , UbaidullaU , AnandV. Design and development of gliclazide mucoadhesive microcapsules: in vitro and in vivo evaluation. AAPS PharmSciTech.9(1), 224–230 (2008).
- Tsiani E , RamlalT , LeiterL , KlipA , FantusI. Stimulation of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide. Endocrinology136(6), 2505–2512 (1995).